IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
412.26
+3.23 (0.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $975.54M in the quarter ending September 30, 2024, with 6.56% growth. This brings the company's revenue in the last twelve months to $3.84B, up 7.16% year-over-year. In the year 2023, IDEXX Laboratories had annual revenue of $3.66B with 8.72% growth.
Revenue (ttm)
$3.84B
Revenue Growth
+7.16%
P/S Ratio
8.88
Revenue / Employee
$349,529
Employees
11,000
Market Cap
33.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 224.45B |
Centene | 146.20B |
Humana | 115.01B |
GE HealthCare Technologies | 19.56B |
IQVIA Holdings | 15.32B |
ResMed | 4.81B |
DexCom | 3.95B |
Veeva Systems | 2.66B |
IDXX News
- 2 days ago - SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX - GlobeNewsWire
- 12 days ago - IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization - Business Wire
- 4 weeks ago - IDEXX Announces CFO Transition - Business Wire
- 5 weeks ago - ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents - Business Wire
- 5 weeks ago - IDEXX Laboratories Q3: Weak End-Market Demand Continues - Seeking Alpha
- 7 weeks ago - IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results - Business Wire
- 7 weeks ago - Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth - Benzinga